The presence of these innate immune cells in RCC tumors enhances the production of vascular endothelial growth factor (VEGF), which is an angiogenic factor that has the potential to promote tumor growth and invasiveness [99, 101] (Fig. 3). Here, VEGFA is linked to neoplasm.